ICN Pharmaceuticals Gets FDA Approval
- Share via
Drug maker ICN Pharmaceuticals Inc. said Tuesday that the U.S. Food and Drug Administration has approved the company’s antifungal medicine Nystatin.
Nystatin is a fungal antibiotic that is used as the active ingredient in a number of prescription anti-fungal medicines. It can be delivered orally, by suppository, or in cream or powder form.
FDA approval brings the latest ICN medicine, made in the Czech Republic, into a competitive U.S. market in which a number of other companies already are selling their own brands of antifungals.
The Costa Mesa company said in a press release that it expects to make Nystatin available to U.S. wholesale suppliers by September.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
